Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders

计划入组 26 人 · 首次发布于 2020 年 2 月 6 日

Stem Cell Applications in Biliary Atresia Patients

计划入组 64 人 · 首次发布于 2024 年 8 月 21 日

Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin

计划入组 20 人 · 首次发布于 2014 年 11 月 11 日

autologous M2 macrophage-secreted proteins

JUV-161

ALP-BCM

Stem Cell Therapeutics Corp

Canada

Stem Cell Medicine Ltd.

Israel

PT. Prodia Stem Cell Indonesia

Juvena Therapeutics Partners with Eli Lilly in AI-Driven Muscle Health Drug Discovery Collaboration

Juvena Therapeutics Initiates First-in-Human Trial of JUV-161 for Muscle Regeneration in Myotonic Dystrophy

Juvena Therapeutics Appoints Julie Anne Smith as CEO as JUV-161 Advances Through Phase 2a